Palisade Bio, Inc. (PALI) has 12 identified peers for comparison in the Healthcare sector. Peers include APGN, CYTO, EFTR, ENVB, IMMX, NAVB and others.
PALI has a market capitalization of $341.72M, compared to an average peer market cap of $93.46M. PALI is significantly larger than its average peer.